Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H I - J - K - L - M N - O - P - Q - R - S T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter G

GENERIC NAME

TRADE NAME

CONDITION

STUDY CODE

STUDY NAME

ACCESS TO STUDY / PROTOCOL

ACCESS TO RESULTS

GEMIGLIPTIN

Zemiglo

Diabetes Mellitus, Type 2

GEMIGL07185

NA

NCT02343926

GIP/GCG/GLP-1 TRIAGONIST

Not Marketed

Obesity

TDU15478

NA

NCT04521738

GLIMEPIRIDE

Amaryl

Diabetes Mellitus, Type 2

EFC10846

NA

NCT00924573

GLIMEPIRIDE

Amaryl

Diabetes Mellitus, Type 2

GLIME_L_04140

SUMER

NCT00957060

GLIMEPIRIDE

Amaryl

Diabetes Mellitus, Type 2

GLIME_L_04409

GREAT

NCT00908921

GLIMEPIRIDE

Amaryl

Diabetes Mellitus, Type 2

HOE490_4038

NA

NCT00353691

GLIMEPIRIDE

Amaryl

Diabetes Mellitus, Type 2

HOE490B_4001

NA

NCT00633425

GLIMEPIRIDE

Amaryl

Diabetes Mellitus, Type 2

GLIME_R_05809

RECOMMEND

NCT01459809

GLIMEPIRIDE - METFORMIN COMBINATION

Amaryl-M

Diabetes Mellitus, Type 2

GLMET_L_04735

DIAGRAM

NCT01204580

GLIMEPIRIDE - METFORMIN COMBINATION

Amaryl-M

Diabetes Mellitus, Type 2

EFC11761

NA

NCT01457911

GLIMEPIRIDE - METFORMIN COMBINATION

Amaryl-M

Diabetes Mellitus, Type 2

GLMET_R_05823

LEGEND

NCT01699932

G-PROTEIN-BIASED S1P1 AGONIST

Not Marketed

Microvascular Coronary Artery Disease

PDY15286

NA

NCT03462017

References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted